This track will explore the latest advancements in radiation therapy techniques and their applications in cancer treatment. Emphasis will be placed on intraoperative radiation therapy and its impact on patient outcomes.

This session will focus on the role of radiology in the diagnosis and management of colorectal cancer. Participants will discuss imaging techniques and their effectiveness in detecting and staging the disease.

This track will delve into the genetic underpinnings of organ-specific cancers and their implications for personalized medicine. Discussions will include the latest research on cancer genetics and targeted therapies.

This session will highlight novel approaches to cancer therapeutics, including anti-cancer drug discovery and development. Participants will share insights on innovative treatment modalities and their clinical applications.

This track will examine the advancements in cancer immunotherapy and stem cell therapy. Experts will discuss the mechanisms of action, clinical trials, and the future landscape of immunotherapeutic strategies.

This session will address the socio-economic implications of cancer diagnosis and treatment. Participants will explore the financial burden of cancer care on patients and healthcare systems.

This track will focus on the latest surgical techniques in oncology, including minimally invasive approaches. Discussions will include the integration of radiology in surgical planning and execution.

This session will cover the role of radiology in diagnosing and managing pediatric tumors, including Wilms tumor and embryonic cell carcinoma. Participants will discuss imaging challenges and advancements in pediatric oncology.

This track will explore the radiographic characteristics and management of soft tissue tumors. Emphasis will be placed on imaging techniques that enhance diagnostic accuracy and treatment planning.

This session will investigate the mechanisms and risk factors associated with radiation-induced cancers. Participants will discuss preventive strategies and the importance of monitoring at-risk populations.

This track will focus on the biology of radiosensitive cancer cells and their implications for treatment. Discussions will include the molecular mechanisms that influence radiosensitivity and potential therapeutic targets.